﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>ClinicalConnection.com New Clinical Trials</title><link>http://www.clinicalconnection.com/NewsWire.aspx</link><description>The latest clinical studies from ClinicalConnection.com - Tomorrow's cures are in clinical trials today!</description><copyright>(c) 1998-2009, ClinicalConnection, Inc. All rights reserved.</copyright><ttl>5</ttl><item><title>Healthy Volunteers - Pasadena CA</title><description>Lotus Clinical Research is conducting a clinical research study of an investigational medication. You must be between 18 to 55 years old to participate. Study participate includes one overnight stay in our facility and 3 follow-up visits. You may be compensated up to $350 for your time and travel. To qualify, you must meet specific study criteria. Give us a call to see if you qualify. </description><link>http://www.clinicalconnection.com/patientviewstudy6430.aspx</link><pubDate>Fri, 20 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Healthy Volunteers (Ages 18-65) - Baltimore MD</title><description>&lt;center&gt;&lt;strong&gt;Research Volunteers Needed&lt;/strong&gt;&lt;/center&gt;&lt;br&gt;&lt;br&gt;

The PAREXEL Clinical Pharmacology Unit, located at Harbor Hospital in Baltimore is currently seeking Volunteers to participate in a clinical research trial to evaluate an Investigational Pet Imaging agent.&lt;br&gt;&lt;br&gt;

We are recruiting the following populations:&lt;ul&gt;
&lt;li&gt; Healthy Males and Females 
&lt;li&gt; Ages 18 -65
&lt;li&gt; Must have no implanted or embedded metal objects throughout your body.&lt;/ul&gt;

The study involves one screening visit, and one in-house stay of 2 nights. &lt;br&gt;&lt;br&gt;

If you qualify and complete the study you may receive up to $ 710.00 in compensation as
Well as the following screening and study evaluations: A Physical, EKG, PET scan, Hepatitis/HIV tests, Blood and Urine analysis at no charge. &lt;br&gt;&lt;br&gt;

Please reference study # 101814-2</description><link>http://www.clinicalconnection.com/patientviewstudy6656.aspx</link><pubDate>Fri, 20 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Hypoactive Sexual Desire Disorder (Females Age 40-65) - St. Louis MO</title><description>&lt;IMG src="http://www.clinicalconnection.com/images/Study6657Flyer.jpg" alt="Are you a post-menopausal woman who is bothered by a decline in sexual desire?
If you are a post-menopausal women, age 40-65, who is bothered by a decline in your sexual desire, you may qualify for a clinical research study of an investigational medication for Hypoactive Sexual Desire Disorder (HSDD).
Compensation for time and travel is available if you qualify."&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6657.aspx</link><pubDate>Fri, 20 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Palm Harbor FL</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6658.aspx</link><pubDate>Fri, 20 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Seattle  WA</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6659.aspx</link><pubDate>Fri, 20 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Aspirin - Rochester MI</title><description>&lt;IMG src="http://www.clinicalconnection.com/images/Study6654Flyer.jpg" alt="Your doctor said aspirin can lower your risk for another heart attack or stroke. But aspirin may raise your risk of stomach ulcers. Local researchers are studying an investigational drug that combines aspirin with a second medication to see if it can help prevent stomach ulcers. You may qualify to participate if you: • Have taken 325 mg of aspirin daily to prevent another heart attack or stroke for the past three months or more and you are either: • Age 18-60 with a documented history of ulcers within the past five years or • Over age 60, with or without a history of ulcers Participants will receive all study-related medical care and diagnostic testing at no cost, and may be compensated for time and travel. To learn more, visit aspirintrial.com. Or contact the local research team:"&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6654.aspx</link><pubDate>Thu, 19 Nov 2009 12:33:29 GMT</pubDate></item><item><title>Healthy Post Menopausal Women - Baltimore MD</title><description>SNBL CPC, Inc. invites you to participate in a research study at our clinical research facility in downtown Baltimore.  We are looking for post menopausal women to participate in a research study involving an investigational medication.  </description><link>http://www.clinicalconnection.com/patientviewstudy6586.aspx</link><pubDate>Wed, 18 Nov 2009 07:13:12 GMT</pubDate></item><item><title>Moderate to Severe COPD - Baltimore MD</title><description>SNBL CPC, Inc. invites you to participate in a research study at our clinical research facility in downtown Baltimore.  We are looking for men and women to participate in a research study involving an investigational medication.  </description><link>http://www.clinicalconnection.com/patientviewstudy6584.aspx</link><pubDate>Wed, 18 Nov 2009 07:05:24 GMT</pubDate></item><item><title>Healthy Volunteers - Baltimore MD</title><description>Participate in a clinical research study evaluating an investigational medication.</description><link>http://www.clinicalconnection.com/patientviewstudy6585.aspx</link><pubDate>Wed, 18 Nov 2009 07:04:27 GMT</pubDate></item><item><title>Atrial Fibrillation - Indiana PA</title><description>Acurian, a company that recruits individuals for clinical research studies, is currently working with a pharmaceutical company to find people who might like to participate in a clinical study regarding atrial fibrillation, sometimes called “afib” or “heart flutter.”&lt;br&gt;&lt;br&gt;
 
If you or a loved one has afib, please allow Acurian to share with you information about this heart study, including the following potential benefits should you qualify to be a part of the study:&lt;ul&gt;

 &lt;li&gt; Study-related health assessments and exams under the supervision of a local study doctor

&lt;li&gt; Investigational study medication at no cost 

&lt;li&gt; Potential compensation for your time and travel&lt;/ul&gt;

If you would like Acurian to share with you information about this research study, please continue below or call toll-free 1-866-246-0579 between 8 a.m. and 10 p.m. Eastern time, Monday through Friday.&lt;br&gt;&lt;br&gt;

Sincerely,&lt;br&gt;&lt;br&gt; 

Christopher Haines, MD

&lt;a title="site stats"
href="http://www.statcounter.com/" target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5070218/0/3f92c63c/1/"
alt="site stats" border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-63");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt; </description><link>http://www.clinicalconnection.com/patientviewstudy6587.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - West Reading PA</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6588.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Wenatchee WA</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6589.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Venice FL</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6590.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Vancouver WA</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6591.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Tucson AZ</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6592.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Trumbull CT</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6593.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Teaneck NJ</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6594.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Tampa FL</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6595.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Tamarac FL</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6596.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Tacoma WA</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6597.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Springfield IL</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6598.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Simpsonville SC</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6599.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Seattle WA</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6600.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Sarasota FL</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6601.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item><item><title>Rheumatoid Arthritis (RA) - Santa Maria CA</title><description>&lt;/span&gt;&lt;/TD&gt;
&lt;/TR&gt;
&lt;TR&gt;
&lt;TD vAlign="top" colspan="3"&gt;
&lt;IMG src="http://www.clinicalconnection.com/images/Study6509Flyer.jpg"&gt;&lt;br&gt;&lt;br&gt;
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide.  The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.&lt;br&gt;&lt;br&gt;
The ORAL trials are made up of six different clinical trials.  Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
&lt;/td&gt;
&lt;/tr&gt;
&lt;TR&gt;&lt;TD vAlign="top" noWrap width="10%"&gt;

&lt;a title="blogspot statistics"
href="http://www.statcounter.com/blogger/"
target="_blank"&gt;&lt;img
src="http://c.statcounter.com/5298023/0/30d8ccb7/1/"
alt="blogspot statistics"
border="0"&gt;&lt;/a&gt;

&lt;script type="text/javascript"&gt;
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
&lt;/script&gt;
&lt;script type="text/javascript"&gt;
try {
var pageTracker = _gat._getTracker("UA-227598-70");
pageTracker._trackPageview();
} catch(err) {}&lt;/script&gt;</description><link>http://www.clinicalconnection.com/patientviewstudy6602.aspx</link><pubDate>Wed, 18 Nov 2009 00:00:00 GMT</pubDate></item></channel></rss>